Ocular myositis as first presenting symptom of human immunodeficiency virus (HIV-1) infection and its response to high-dose cortisone treatment. NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Ocular myositis as first presenting symptom of human immunodeficiency virus (HIV-1) infection and its response to high-dose cortisone treatment.

Br J Ophthalmol. 1991 Nov;75(11):696-7. Unique Identifier : AIDSLINE MED/92089048
Fabricius EM; Hoegl I; Pfaeffl W; Department of Ophthalmology, Harlaching Hospital, Munchen,; Germany.

Abstract: A 30-year-old male presented with signs of ocular inflammation and motility disturbances in an early stage of HIV infection. The provisional diagnosis of an ocular myositis was confirmed by orbital echograms. A general check up revealed positive anti-smooth-muscle antibodies and antinuclear antibodies as well as a raised erythrocyte sedimentation rate. Oral steroid treatment in addition to steroid eyedrops achieved complete resolution of clinical and sonographic symptoms within 15 weeks. Autoimmune phenomena are well known presentations of HIV infection. In this case oral cortisone proved to be an effective therapy even in the setting of an HIV infection.
Keywords: Acquired Immunodeficiency Syndrome/*COMPLICATIONS Adult Antibodies, Antinuclear/ANALYSIS Autoantibodies/ANALYSIS Case Report Cortisone/*THERAPEUTIC USE Eye Infections, Viral/*COMPLICATIONS Human Male Muscle, Smooth/IMMUNOLOGY Myositis/*COMPLICATIONS/DRUG THERAPY/IMMUNOLOGY Oculomotor Muscles Support, Non-U.S. Gov't JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/KWDcomplicationsadultantibodies,antinuclear/analysisautoantibodies/analysiscasereportcortisone/KWDtherapeuticuseeyeinfections,viral/KWDcomplicationshumanmalemuscle,smooth/immunologymyositis/KWDcomplications/drugtherapy/immunologyoculomotormusclessupport,non-uKWDsKWDgov'tjournalarticle
920430
M9240918

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .